Warren S. Orlando joined Neuvana as Chairman of the Board in 2018. Formerly he was the founder, chairman, and chief executive officer of two successful commercial bank holding companies. He grew and sold both banks over a 23 year period—raising over $100 million in private equity, leading an initial public offering for both companies, initiating secondary offerings, and raising over $250 million in public funds. Mr. Orlando was the lead on 23 acquisitions and related integrations. He holds a BS in Economics from St. Peters College and a master’s degree from the Stonier School of Banking, Rutgers University. Mr. Orlando is currently vice chairman of the board at Boca Raton Regional Hospital.
Board Vice-Chairman and Inventor
Richard Cartledge, MD, FACS, has been chief of cardiac surgery of Boca Raton Regional Hospital since 2013. He is fellowship trained in cardiovascular surgery from New York Hospital/Weill Cornell Medical Center and in thoracic surgical oncology from Memorial Sloan Kettering. Along with his brother, Dr. Daniel Cartledge, MD, he invented and patented the Neuvana vagus nerve stimulation device and started Neuvana, LLC, in 2015. He has over 20 years’ experience inventing, designing, and manufacturing cutting-edge medical devices with more than 80 issued and pending patents. Dr.Cartledge holds a BS in Mechanical Engineering from Lehigh University and a medical degree from the Medical College of Pennsylvania.
Chief Executive Officer and Director
John Marino, CPA, joined Neuvana as CEO in 2018. He has been the CFO and president of several startup and public companies. Mr. Marino has been involved in over $200 million in private equity and debt fundings and has led three company initial public offerings and numerous secondary offerings raising over $500 million in public equity. He managed, grew and sold two of the companies and guided the acquisition and integrations of 26 other companies. Mr. Marino holds an accounting degree from Stetson University.
Director and Inventor
Daniel Cartledge, MD, practices at the National Pain Institute in Delray Beach, Florida, and specializes in interventional pain medicine. He’s an expert in neuro-electrical therapies to treat patients with chronic pain. He serves as Medical Director of a therapeutic infusion clinic and is on the advisory board of two nutraceutical companies. Dr. Cartledge is double-board certified in pain management and physical medicine and rehabilitation. Along with his brother, Dr. Richard Cartledge, MD, he invented and patented the Neuvana vagus nerve stimulation device and started Neuvana, LLC, in 2015. Dr. Cartledge holds an undergraduate degree from Lehigh University and a medical degree from the University of Saint Eustatius School of Medicine.
Jan Carlsson is the Managing Partner of LFC Development and the Manager of Lynn Family Enterprises. He has served two decades on the Board of Trustees at Lynn University and has extensive professional experience in mergers, acquisitions, restructuring and valuation of companies. He holds an MBA in International Business and Finance from the University of Miami.
Chief Operating Officer
Vincent C. Manopoli has worked as chief executive officer, chief operating officer, and managing partner to numerous startups and turnaround businesses over the past 35 years. Mr. Manopoli has extensive experience in a variety of sectors including software, pharmaceuticals, medical devices, and healthcare management. He holds a BS in Chemistry from UC Irvine, an MS in Chemistry from Cal State Fullerton, and an MBA from the Drucker School and Yale University.
VP Business Development& Customer Experience
Ami Brannon is a founder of Neuvana, LLC, and was formerly chief executive officer of the company. She has over 20 years of experience in hospital-based healthcare and an extensive background in developing relationships and marketing in the bio-stimulation market. Ms. Brannon holds a BS in Nursing and a BS in Psychology from the University of Central Florida.
Director of Engineering
Kermit Arthur Falk has been the director of engineering at Neuvana, LLC, since January 2015. Working closely with Dr. Richard Cartledge, MD, and Dr. Daniel Cartledge, MD, Mr. Falk has led the research and development of the company. He has extensive knowledge and experience developing technology at both the research and development and commercially available levels. Mr. Falk has a BS in Mechanical Engineering from Georgia Tech and a MS in Engineering from Johns Hopkins University.